2.73
price up icon18.70%   0.43
after-market Handel nachbörslich: 2.74 0.01 +0.37%
loading

Humacyte Inc Aktie (HUMA) Neueste Nachrichten

pulisher
02:52 AM

Humacyte rises on Symvess sale to military treatment facility - MSN

02:52 AM
pulisher
11:45 AM

Humacyte Inc. Equity Warrant Stock Analysis and ForecastRapid wealth multiplication - jammulinksnews.com

11:45 AM
pulisher
11:41 AM

Humacyte shares climb 6% after first Symvess sale to U.S. military hospital - MSN

11:41 AM
pulisher
10:32 AM

Is Humacyte Inc. Equity Warrant a good long term investmentUnprecedented profit potential - Autocar Professional

10:32 AM
pulisher
09:15 AM

Humacyte stock rises after first Symvess sale to US Military facility - Investing.com India

09:15 AM
pulisher
08:17 AM

Humacyte Announces First Symvess™ Sale to Military Treatment Facility - The Manila Times

08:17 AM
pulisher
08:00 AM

Humacyte Breaks Into Military Healthcare: FDA-Approved Symvess Now Serving 200,000 Military Personnel - Stock Titan

08:00 AM
pulisher
07:41 AM

What drives Humacyte Inc. stock priceFree Consultation - Autocar Professional

07:41 AM
pulisher
12:11 PM

What analysts say about Humacyte Inc. stockMassive profits - jammulinksnews.com

12:11 PM
pulisher
Jul 22, 2025

Humacyte Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Humacyte Inc. a good long term investmentOutstanding risk-reward balance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Humacyte Inc. Equity Warrant stockConsistently profitable trades - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Humacyte Inc. Equity Warrant stock priceFree Stock Selection - Autocar Professional

Jul 21, 2025
pulisher
Jul 19, 2025

Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know - MSN

Jul 19, 2025
pulisher
Jul 17, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) Shareholders - ACCESS Newswire

Jul 17, 2025
pulisher
Jul 16, 2025

Humacyte outlines expansion of Symvess to 45 hospitals while targeting BLA submission for ATEV in dialysis by 2026 - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today - MSN

Jul 16, 2025
pulisher
Jul 13, 2025

Lobbying Update: $10,000 of HUMACYTE lobbying was just disclosed - Nasdaq

Jul 13, 2025
pulisher
Jul 12, 2025

Humacyte jumps as DoD issues ECAT listing approval for Symvess - MSN

Jul 12, 2025
pulisher
Jul 10, 2025

Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN

Jul 10, 2025
pulisher
Jul 09, 2025

Positive week for Humacyte, Inc. (NASDAQ:HUMA) institutional investors who lost 56% over the past year - simplywall.st

Jul 09, 2025
pulisher
Jul 09, 2025

Humacyte's Symvess ECAT Listing: A Strategic Catalyst for Biotech's Comeback - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Humacyte’s Symvess gains DOD electronic catalog listing approval By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 09, 2025

Humacyte's Symvess ECAT Approval: A Strategic Play for Dominance in Vascular Trauma and Beyond - AInvest

Jul 09, 2025
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):